Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β

Cited by (168)

Items 101–168 of 168

1. Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
   Tiago Siqueira de Sousa, Paula Isabel Moreira, Susana Cardoso · 2023 · Biomedicines
2. Emerging role of Metformin in Alzheimer’s disease: A translational view
   Juvenal A. Ríos, Juan Carlos Bórquez, Juan Alejandro Godoy, Juan Manuel Zolezzi, María Cristina Furrianca, Nibaldo C. Inestrosa · 2024 · Ageing Research Reviews
3. Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease
   Vı́ctor Tapias, Paula González-Andrés, Laura Fernández-Peña, Asunción Barbero, Lucı́a Núñez, Carlos Villalobos · 2023 · Antioxidants
4. Ferroptosis in Alzheimer’s Disease: The Regulatory Role of Glial Cells
   Jingyi Xu, Rongjing Shen, Mengting Qian, Zhengjun Zhou, Bingqing Xie, Yong Qing Jiang, Yang Yu, Wei Dong · 2025 · Journal of Integrative Neuroscience
5. The role of ferroptosis in Alzheimer's disease: Mechanisms and therapeutic potential (Review)
   Heng Zeng, Zhaohui Jin · 2025 · Molecular Medicine Reports
6. Ginsenoside Rg1, lights up the way for the potential prevention of Alzheimer's disease due to its therapeutic effects on the drug-controllable risk factors of Alzheimer's disease
   Jiaojiao Wu, Li Zhang, Dong Liu, Jia Xia, Yu Yang, Fei Tang, Lu Chen, Hui Ao, Cheng Yun Peng · 2023 · Journal of Ethnopharmacology
7. Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non‐human primate models
   Zhihui Jin, Yan Lu, Huifang Tang, Huashun Cui · 2025 · Alzheimer s & Dementia
8. Indirubin-3′-monoxime suppresses amyloid-beta- induced apoptosis by inhibiting tau hyperphosphorylation
   Xiaoshan Wang, Shu-gang Zhang, Yingdong Zhang, Qing Di, Jingping Shi, Min Qian, Li-gang Xu, Xingjian Lin, Jie Lu · 2016 · Neural Regeneration Research
9. Deficiency but Not Supplementation of Selenium Impairs the Hippocampal Long-Term Potentiation and Hippocampus-Dependent Learning
   Ercan Babür, Burak Tan, Marwa Yousef, Sümeyra Cinbaş, Cem Süer, Nurcan Dursun · 2019 · Biological Trace Element Research
10. Ipriflavone as a non‐steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice
    Rui-fang Nie, Jian Lu, Rui Xu, Juanzhen Yang, Xingyi Shen, Xingnan Ouyang, Danyang Zhu, Yujie Huang, Xuejian Zhao, Xuejian Zhao et al. · 2022 · Aging Cell
11. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice
    Julia Gamache, Lisa J. Kemper, Elizabeth L. Steuer, Kailee Leinonen-Wright, Jessica M. Choquette, Chris J.W. Hlynialuk, Kellie A. Benzow, Keith A. Vossel, Weiming Xia, Michael D. Koob et al. · 2019 · Journal of Neuroscience
12. The reduction of astrocytic tau prevents amyloid-β-induced synaptotoxicity
    Pablo Cisternas, Xavier Taylor, Pablo Martínez, Orlando Maldonado, Nur Jury, Cristian A. Lasagna‐Reeves · 2022 · Brain Communications
13. Ferroptosis: A new strategy for targeting Alzheimer’s disease
    Rong Rong Qiang, Yang Xiang, Lei Zhang, Xin Yue Bai, Die Zhang, Yang Jing Li, Yan Ling Yang, Xiao Long Liu · 2024 · Neurochemistry International
14. A review of mitochondrial dysfunction, pathophysiology and therapeutic prospects in neurodegenerative diseases
    Joshua Ayodele Yusuf, Stephen Tunmise Akanbi, Margaret Seun Ijibadejo, Swabirah Enimire Sulaiman, Darasimi Racheal Olorunlowu, Aishat Olajumoke Akinola, Abimbola Peace Abe, Elizabeth Kehinde Opoola, Emmanuel Oluwagbenga Adejobi, Tunmise David Adigun et al. · 2025 · Discover Neuroscience
15. 4R Tau Modulates Cocaine-Associated Memory through Adult Dorsal Hippocampal Neurogenesis
    Hong-Chun Li, Wei Xu, Denian Wang, Liang Wang, Qiyao Fang, Xuemei Wan, Jiamei Zhang, Yi-Ming Hu, Hui-Fang Li, J Zhang et al. · 2021 · Journal of Neuroscience
16. Ovariectomy increases the age-induced hyperphosphorylation of Tau at hippocampal CA1
    Ofir Picazo, Judith Espinosa‐Raya, Alfredo Briones-Aranda, Marco Antonio Cerbón · 2016 · Cognitive Processing
17. Disrupted mitochondrial response to nutrients is a presymptomatic event in the cortex of the APPSAA knock‐in mouse model of Alzheimer's disease
    Andrés Norambuena, Vijay Kumar Sagar, Zhuoying Wang, Prakash Raut, Ziang Feng, Horst Wallrabe, Evelyn Pardo, Taylor Kim, Shagufta Rehman Alam, Song Hu et al. · 2024 · Alzheimer s & Dementia
18. PP2A and GSK3 act as modifiers of FUS-ALS by modulating mitochondrial transport
    Paraskevi Tziortzouda, Jolien Steyaert, Wendy Scheveneels, Adrià Sicart, Katarina Stoklund Dittlau, Adriana Margarida Barbosa Correia, Thibaut Burg, Arun Pal, Andreas Hermann, Philip Van Damme et al. · 2024 · Acta Neuropathologica
19. Pathobiolgy and Management of Alzheimer's Disease
    Hoowon Kim, Ji Yeon Chung · 2021 · Chonnam Medical Journal
20. Molecular sabotage of hippocampal synaptic plasticity by amyloid-β in Alzheimer's disease: A narrative review
    Zahra Behroozi, Hedyeh Askarpour, Yousef Baghcheghi · 2026 · Journal of Alzheimer s Disease Reports
21. Amyloid-beta peptide toxicity in the aged brain is a one-way journey into Alzheimer’s disease
    Georgia R. Culley, Alexandre Henriques, Delphine Hardy, Alexandre Wojcinski, Adrien Chabert, Bilal El Waly, Philippe Poindron, Noëlle Callizot · 2025 · Frontiers in Aging Neuroscience
22. Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools
    Vanlalrinchhani Varte, Jeremy W Munkelwitz, Diego E. Rincón-Limas · 2023 · Frontiers in Neuroscience
23. Influence of palmitoylation in axonal transport mechanisms in neurodegenerative diseases
    B. S. Praveen, Priti Talwar · 2025 · Frontiers in Cellular Neuroscience
24. Effects of schisandrin B on hypoxia-related cognitive function and protein expression in vascular dementia rats
    Jingbo He, He Zhang, Hongxia Zheng, Jianxin Jia, Yichi Zhang, Xu-Sheng Yan, Xiaoxu Li, Kai-Wen Wei, Jun J. J. Mao, Hong Chen et al. · 2024 · Journal of Toxicology and Environmental Health
25. Kinesin‐1 inhibits the aggregation of amyloid‐β peptide as detected by fluorescence cross‐correlation spectroscopy
    Yan-Peng Zheng, Shijun Tian, Xiang-Lei Peng, Jingfa Yang, Yuan-Hui Fu, Yue-Ying Jiao, Jiang Zhao, Jinsheng He, Tao Hong · 2016 · FEBS Letters
26. White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis
    Yi‐Chia Wei, Yi‐Chia Kung, Ching‐Po Lin, Chih‐Ken Chen, Chemin Lin, Rung-Yu Tseng, Yao-Liang Chen, Wen‐Yi Huang, Pin‐Yuan Chen, Shin Tai Chong et al. · 2024 · Behavioral and Brain Functions
27. Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice
    Carolina Lucía Facal, Iván Fernández Bessone, Javier Andrés Muñiz, A. Ezequiel Pereyra, Olivia Pedroncini, Indiana Páez-Paz, Ramiro Clerici-Delville, Cayetana Arnaiz, Leandro Urrutia, Germán Falasco et al. · 2024 · Molecular Therapy
28. A Polyaminobiaryl-Based β-secretase Modulator Alleviates Cognitive Impairments, Amyloid Load, Astrogliosis, and Neuroinflammation in APPSwe/PSEN1ΔE9 Mice Model of Amyloid Pathology
    Marie Tautou, Florian Descamps, Paul-Emmanuel Larchanché, Luc Buée, Jamal El Bakali, Patricia Melnyk, Nicolas Sergeant · 2023 · International Journal of Molecular Sciences
29. Tau Protein Aggregation Inhibitors—Therapeutic Strategy for Concurrent Tau and Amyloid Aggregation Inhibition
    Thomas Gabriel Schreiner, Romeo Cristian Ciobanu, Oliver Daniel Schreiner · 2026 · Biomedicines
30. Tau depletion diminishes vascular amyloid-related deficits in a mouse model of cerebral amyloid angiopathy
    Jury‐Garfe, Nur, Chimal‐Juárez, Enrique, Patel, Henika, Martinez‐Pinto, Jonathan, Vanderbosch, Kathryn, Mardones, Muriel D., Perkins, Abigail, Prisco, Gonzalo Viana Di, Marambio, Yamil, Vidal, Ruben et al. · 2025 · Alzheimer's & Dementia
31. From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape
    Anastasia M. Bougea, Manuel Debasa‐Mouce, Shelly Gulkarov, Mónica Castro‐Mosquera, Allison Bethanne Reiss, Alberto Ouro · 2025 · Medicina
32. Mécanismes, facteurs de risque et stratégies thérapeutiques dans la maladie d’Alzheimer
    Michel Maître, Christian Klein, Ayikoe Guy Mensah‐Nyagan · 2017 · NPG. Neurologie, psychiatrie, gériatrie/NPG
33. Axonal Transport Impairment and its Relationship with Diffusion Tensor Imaging Metrics of a Murine Model of p301L Tau Induced Tauopathy
    Christopher Nishioka, Hsiao‐Fang Liang, Stephen Ong, Shu‐Wei Sun · 2022 · Neuroscience
34. FTLD-MAPT mutations and short 5′UTR Tau mRNAs increase Tau translation
    Paulo J. da Costa, Antoine Perret, Luc Buée, Malika Hamdane, Franck Martin · 2024 · NAR Molecular Medicine
35. Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation
    Gregory A. Mohl, Gary Dixon, Emily Marzette, Justin McKetney, Avi J. Samelson, Carlota Pereda Serras, Julianne Jin, Nabeela Ariqat, Andrea Keys, Cristian Chavira et al. · 2026 · npj Dementia
36. Seizures and Epilepsy in Dementia: Diagnosis and Management
    Laura Mantoan Ritter, Christer Nilsson · 2021 · Springer eBooks
37. New Targets for Diagnosis and Treatment Against Alzheimer’s Disease: The Mitochondrial Approach
    Maria Jose Perez J., Claudia Jara, Ernesto Muñoz-Urrutia, Rodrigo A. Quintanilla · 2016 · InTech eBooks
38. The Default Mode Network and Executive Function
    Christopher Brown · 2017 · UKnowledge (University of Kentucky)
39. Neurodegenerative Diseases and Axonal Transport
    Lawrence S.B. Goldstein, Utpal Das · 2018 · Elsevier eBooks
40. ASO targeting temperature-controlled RBM3 poison exon splicing prevents neurodegeneration in vivo
    Marco Preußner, Heather Smith, Min Zhang, Daniel Hughes, Ann‐Kathrin Emmerichs, Silvia Scalzitti, Diego Peretti, Dean Swinden, Alexander Neumann, Tom Haltenhof et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
41. Novel Effective Small-Molecule Inhibitors of Protein Kinases Related to Tau Pathology in Alzheimer's Disease
    Ansgar Opitz, Lisa-Marie Seitz, Vladimı́r Kryštof, Fady Baselious, Max Holzer, Wolfgang Sippl, Andreas Hilgeroth · 2022 · Future Medicinal Chemistry
42. Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease
    Sara Akhtar Khan, Khushi Raza, Prachi Tiwari, Mohamed El‐Tanani, Syed Arman Rabbani, Suhel Parvez · 2026 · Frontiers in Aging Neuroscience
43. Gastrodin Alleviates Tau Hyperphosphorylation Associated with AKT/GSK-3β Signaling Changes in an Alzheimer's Disease Cell Model
    Hongyao Li, Xiaoqi Wu, Guang Wu, Jianjun Guo, Zuoming Nie, Qing Sheng · 2026 · Journal of Visualized Experiments
44. Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer’s disease therapy
    Alberto Ouro, Gabriel A. Ben-Dor, Manuel Debasa‐Mouce, Shelly Gulkarov, Joshua De Leon, Mónica Castro‐Mosquera, Tomás Sobrino, Anastasia M. Bougea, Allison Bethanne Reiss · 2026 · Frontiers in Cell and Developmental Biology
45. The mitochondria-synapse axis in Alzheimer’s disease: Lost coordination in early stages
    Priyanshu Sharma, Navneet Kaur, Nandini Vasal, Kusum Solanki, Aditya Sunkaria · 2026 · Ageing Research Reviews
46. Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease ☆
    Gabriel S. Stephens, Jason C. You, Chia-Hsuan Fu, Jeannie Chin · 2017 · Elsevier eBooks
47. Tau interferes with axonal neurite stabilization and cytoskeletal composition independently of its ability to associate with microtubules
    Edward F. Boumil, Rishel Brenna Vohnoutka, Sangmook Lee, Thomas B. Shea · 2020 · Biology Open
48. Targeted degradation of microtubule-associated protein tau using an engineered nanobody-E3 ubiquitin ligase adapter fusion
    Shiyao Wang, Shaowei Jiang, Guoan Zheng, Yong Ku Cho · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
49. Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease
    Chimal-Juárez, Enrique, Patel, Henika, Jury-Garfe, Nur, Dabin, Luke C., Vidal, Ruben, Kim, Jungsu, Lasagna-Reeves, Cristian A. · 2026 · bioRxiv
50. Regulation of the kinesin-3 motor, KIF1A, in a cellular model of Alzheimer’s disease
    Aumbreen Akram · 2016 · Summit (Simon Fraser University)
51. Investigating the mechanisms underlying Alzheimer's disease using a novel organotypic brain slice culture model
    Cara L. Croft · 2016 · Research Portal (King's College London)
52. Investigating how kinesin and dynein walk on complex microtubule surfaces
    Luke S. Ferro · 2020 · eScholarship (California Digital Library)
53. Tau reduction prevents Aß-induced axonal transport deficits by blocking activation of GSK3ß
    Keith A. Vossel, J Xu, Vira Fomenko, T. Miyamoto, Elsa Suberbielle, Joseph A. Knox, K. Ho, D Kim, G Yu, Lennart Mucke · 2015 · The Journal of Experimental Medicine
54. Faculty Opinions recommendation of Tau deletion reduces plaque-associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease.
    Riqiang Yan · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
55. Alzheimer's disease: therapeutic potential of phytocannabinoids
    Terezinha Carla Carvalho da Silva, Anderson Ramos da Silva, Caroline Helena da Silva Campagnone, Antônio J. Alves, Valdemiro Amaro da Silva · 2024 · Concilium
56. Copy number variations of proteins associated with neurodegenerative diseases and rare neurological disorders
    Zhangzhong Yang, Peng Lei · 2024 · Scientia Sinica Vitae
57. Autophagy intersection: Unraveling the role of the SNARE complex in lysosomal fusion in Alzheimer's disease
    Siyu Li, Yangyang Wang, Xiao Liang, Yu Li · 2025 · Journal of Alzheimer s Disease
58. Selective disruption of tau–SH3 interactions rescues seizure and sleep phenotypes
    Mayank Shandilya, Anne Koutures, Kwaku Addo-Osafo, Kaylin Hwang, Mariane Cristine Vicente, Ashley N. Ewens, Brittany M. Katz, Sam Peters, Jessica M. Choquette, Rahil N. Vaknalli et al. · 2026 · Brain
59. MT5-MMP promotes neuroinflammation, pathogenic processing of amyloid precursor protein and synaptic dysfunction at early stages in an Alzheimer's disease model
    Dominika Piłat · 2021 · theses.fr (ABES)
60. Développement d’une méthode de mesure et d’analyse du transport intraneuronal dans le cerveau de larve de poissons-zèbre par suivi de nanocristaux non-linéaires en microscopie de second-harmonique : application à l’étude d’anomalies de transport chez des poissons portant une mutation retrouvée dans des neuropathies humaines.
    Fériel Terras · 2020
61. Chronic stress and glucocorticoid actions in brain plasticity and Tau pathology
    Chrysoula Dioli · 2021 · theses.fr (ABES)
62. Targeting autophagy-related serine/threonine kinases to combat neurodegenerative disorders
    Wei Liu, Bo Liu · 2026 · Elsevier eBooks
63. Regulation of different kinases for Alzheimer's disease therapy: progresses and perspectives
    Menglin Han, Qinghong Liao, Siyu He, Lina Guo, Ziyao Lu, Xiaohan Wang, Wen Sun, Y. B. Duan, Weiping Lyu, Qi Li · 2026 · Bioorganic Chemistry
64. Evaluation the role of quinoa seeds in attenuation the brain cellular senescence and aging induced by D-galactose and γ-radiation in rats: insights into autophagy, telomerase activity, amyloid-β and tau proteins
    Merehan Alaa-ElDin. Mohamed, Mustafa M. M. Elbakry, Nermeen M El Bakary, Said Salama Moselhy, Youssef A. Said · 2026 · Inflammopharmacology
65. Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases
    Haiwen Wang, Xing Fan, Jianchao Ping, Qian Shao, Wang Cai, Hao Wang, Qiuhong Ji, Min Su, Wei Qian · 2026 · Translational Neurodegeneration
66. Tau phosphorylation from neuronal adaptation to Alzheimer’s disease
    R Trouvé, Patrik Verstreken, Marieke MB Hoekstra · 2026 · Neuron
67. Selective neuronal vulnerability in Alzheimer’s disease: Mechanisms, biomarkers, and therapeutic implications
    Tian-Yang Xu, E Er-Deng, Ting Zhang, Zhang Xiao-Qin · 2026 · Ageing Research Reviews
68. APH-1A and CDK5 Expression Correlates with Tau Hyperphosphorylation and Its Attenuation by Brahmi and Donep-M in STZ induced Alzheimer’s Disease Model
    Umesh Prasad Sah Hathi, Abhishek Kumar, Arora Jyotsna, Suneel Kateriya · 2026 · Research Square